In a ruling handed down today (27 March) by the UK Supreme Court, Lord Hodge has confirmed that discoveries made through well-established or routine research protocols can be inventive and rewarded with a patent
The Government last night committed to further consultation with the BIA on the UK’s future Intellectual Property rights regime in the event of a ‘no deal’ Brexit following concerns raised in the House of Lords.
New figures published today (Thursday 24 January 2019) by the UK BioIndustry Association (BIA) and Informa Pharma Intelligence reveal that the UK biotech sector raised a record £2.2 billion from investors in 2018. The total is the best ever recorded by the trade association and almost double that raised in 2017.
The data is presented in the report Confident capital: backing UK biotech and launched by the Exchequer Secretary to the Treasury, Robert Jenrick MP, at the BIA's Strategic Technologies event in central London today.
Steve Bates OBE, CEO of the BIA said:
“It’s great to see the UK government and NHS committed to exploring a new payment model for antibiotics in our market. The UK took a lead in putting Anti Microbial Resistance (AMR) on the global agenda and it’s really good to see it taking a first mover advantage on innovative pricing and reimbursement for AMR.
The BIA welcomes the announcement of Nicola Blackwood as new Parliamentary Under-Secretary of State for Health.
BIA CEO, Steve Bates OBE, said: “As a former health minister and former chair of the science and technology committee, and serving as a board member of Eagle Genomics, Nicola knows our sector well and is well-placed to hit the ground running. We had a strong relationship with Nicola when she was minister for health, and we look forward to working with her to ensure the UK stays a world-leader in the life sciences.”
Today the Health Secretary Matt Hancock has written to pharmaceutical companies to update them on progress made on human medicines supply in March 2019 “no deal scenario” with some updates to the Government planning assumptions.
Today the government has published the second Life Sciences Sector Deal. The document details both public and private sector investments into the sector, including a £1bn research and development investment from BIA member company UCB and a new partnership between government and industry using artificial intelligence to develop the next generation of treatments.
The BioIndustry Association has today announced that Action Medical Research for children will be its Charity of the Year for 2019. The partnership will be formally launched at the BIA Gala Dinner on 24 January 2019. Proceeds from a silent auction, table donations and pledges on the night will be donated to Action Medical Research for children, and attendees will hear from Simon Harriss, dad to 10-year-old Lily who has a devastating neurological condition called BPAN.
This week marked the relaunch of the All Party Parliamentary Group (APPG) for Life Sciences. Chaired by Daniel Zeichner MP, the APPG will raise awareness of UK life sciences among parliamentarians and explore the challenges and opportunities facing the sector.